Pharma Penny Stock Under Rs 50 Approves FY25 Audited Results; Recommended Rs 0.10 Dividend & Approves Rs 37.22 Cr Acquisition in Trimax Bio Sciences
Pharma Penny Stock Under Rs 50 Approves FY25 Audited Results; Recommended Rs 0.10 Dividend & Approves Rs 37.22 Cr Acquisition in Trimax Bio Sciences
From Rs 34.51 per share (52-week low) to Rs 53.59 per share, the stock is up by 55.3 per cent.
From Rs 34.51 per share (52-week low) to Rs 53.59 per share, the stock is up by 55.3 per cent.
Low PE pharma penny stock below Rs 60 jumps 14.50 per cent after reporting turnaround net profit of Rs 25 crore in FY25
The company has a market cap of over Rs 300 crore and the stock is up by 16.34 per cent from its 52-week low of Rs 49.20 per share.
The company has a market cap of over Rs 300 crore and the stock is up by 16.34 per cent from its 52-week low of Rs 49.20 per share.
40 Per Cent Returns from 52-Week Low; Board Announce 1:1 Bonus Shares and 30 Per Cent Dividend
The stock is up over 40 per cent from its 52-week low of Rs 148.05 per share.
The stock is up over 40 per cent from its 52-week low of Rs 148.05 per share.
2:1 Stock Split: Gujarat-Based Penny Stock Under Rs 2 Hit Upper Circuits as PAT Jumps 14,940 Per Cent in FY25
The stock is trading at 0.65 times its book value and the stock is up by 36 per cent from its 52-week low of Rs 1.04 per share.
The stock is trading at 0.65 times its book value and the stock is up by 36 per cent from its 52-week low of Rs 1.04 per share.
47 Per Cent Returns from 52-Week Low; Board Likely to Announce Bonus Shares and Dividend
The stock is up by 47 per cent from its 52-week low of Rs 148.05 per share.
The company has a market cap of over Rs 1,000 crore and has delivered good profit growth of 19 per cent CAGR over the last 5 years with a healthy dividend payout of 26 per cent.
CuraTeQ Biologics receives approval for Biosimilar Zefylti from the UK’s MHRA
The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 52-week low of Rs 994.35 per share.
The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 52-week low of Rs 994.35 per share.
Multibagger Pharma Stock Under Rs 50 To Be in Focus Today as Company Acquires 100 Per Cent Stake in Cibachem General Trading L.L.C
The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.
The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.
From Rs 5.83 to Rs 29.69 Per Share in Just 11 Months & 10 Days: Multibagger Pharma Stock Hit Upper Circuit for Second Straight Day
The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.
The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.
Promoters hold 66 per cent stake: Pharma penny stock jumps 8.5 per cent; Do You Own It?
The company has a market cap of over Rs 300 crore and the stock is up by 12.4 per cent from its 52-week low of Rs 50.42 per share.
The shares of the company have a PE of 12x whereas the industry PE is 30x.
Pharma Penny Stock Below Rs 20: Company Receives Order Worth Rs 12,59,50,000 from J D Healthcare
The stock is up by 44 per cent from its 52-week low of Rs 12.33 per share.
The stock is up by 44 per cent from its 52-week low of Rs 12.33 per share.
Pharma Penny Stock Under Rs 50 Jumps After Company Successfully Achieved Certificate of Suitability (CEP) for Metformin Hydrochloride from European Directorate
From Rs 34.51 per share (52-week low) to Rs 41.39 per share, the stock is up by 20 per cent. .
From Rs 34.51 per share (52-week low) to Rs 41.39 per share, the stock is up by 20 per cent. .
Multibagger Pharma Stock Under Rs 30: Company Reports a 45 Per Cent Jump in PAT & FIIs Bought 1,29,48,000 Shares
The stock gave multibagger returns of 358 per cent from its 52-week low of Rs 5.82 per share.
The stock gave multibagger returns of 358 per cent from its 52-week low of Rs 5.82 per share.